vs
LivaNova PLC（LIVN）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LivaNova PLC的季度营收约是LiveRamp Holdings, Inc.的1.7倍（$360.9M vs $212.2M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 8.6%，领先10.2%），LivaNova PLC同比增速更快（12.1% vs 8.6%），过去两年LiveRamp Holdings, Inc.的营收复合增速更高（11.1% vs 10.6%）
LivaNova PLC是一家深耕医疗设备领域的企业，总部位于英国，核心业务为研发心脏外科及神经调控类医疗设备。该公司由美国Cyberonics公司与意大利Sorin公司于2015年以27亿美元对价合并成立，目前在纳斯达克挂牌交易，股票代码为LIVN。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
LIVN vs RAMP — 直观对比
营收规模更大
LIVN
是对方的1.7倍
$212.2M
营收增速更快
LIVN
高出3.6%
8.6%
净利率更高
RAMP
高出10.2%
8.6%
两年增速更快
RAMP
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $360.9M | $212.2M |
| 净利润 | $30.9M | $39.9M |
| 毛利率 | 65.2% | 71.9% |
| 营业利润率 | 11.8% | 18.6% |
| 净利率 | 8.6% | 18.8% |
| 营收同比 | 12.1% | 8.6% |
| 净利润同比 | -44.7% | 255.7% |
| 每股收益（稀释后） | $0.57 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LIVNRAMP
| Q4 25 | $360.9M | $212.2M | ||
| Q3 25 | $357.8M | $199.8M | ||
| Q2 25 | $352.5M | $194.8M | ||
| Q1 25 | $316.9M | $188.7M | ||
| Q4 24 | $321.8M | $195.4M | ||
| Q3 24 | $318.1M | $185.5M | ||
| Q2 24 | $318.6M | $176.0M | ||
| Q1 24 | $294.9M | $171.9M |
净利润LIVNRAMP
| Q4 25 | $30.9M | $39.9M | ||
| Q3 25 | $26.8M | $27.4M | ||
| Q2 25 | $27.2M | $7.7M | ||
| Q1 25 | $-327.3M | $-6.3M | ||
| Q4 24 | $55.9M | $11.2M | ||
| Q3 24 | $33.0M | $1.7M | ||
| Q2 24 | $16.3M | $-7.5M | ||
| Q1 24 | $-41.9M | $-5.4M |
毛利率LIVNRAMP
| Q4 25 | 65.2% | 71.9% | ||
| Q3 25 | 68.4% | 70.2% | ||
| Q2 25 | 67.8% | 70.1% | ||
| Q1 25 | 69.7% | 69.3% | ||
| Q4 24 | 68.2% | 71.9% | ||
| Q3 24 | 70.8% | 72.4% | ||
| Q2 24 | 68.7% | 70.6% | ||
| Q1 24 | 70.3% | 72.2% |
营业利润率LIVNRAMP
| Q4 25 | 11.8% | 18.6% | ||
| Q3 25 | 15.1% | 10.7% | ||
| Q2 25 | 15.4% | 3.7% | ||
| Q1 25 | 15.3% | -6.1% | ||
| Q4 24 | 11.5% | 7.5% | ||
| Q3 24 | 11.2% | 4.0% | ||
| Q2 24 | 12.6% | -3.0% | ||
| Q1 24 | 5.5% | -8.3% |
净利率LIVNRAMP
| Q4 25 | 8.6% | 18.8% | ||
| Q3 25 | 7.5% | 13.7% | ||
| Q2 25 | 7.7% | 4.0% | ||
| Q1 25 | -103.3% | -3.3% | ||
| Q4 24 | 17.4% | 5.7% | ||
| Q3 24 | 10.4% | 0.9% | ||
| Q2 24 | 5.1% | -4.3% | ||
| Q1 24 | -14.2% | -3.1% |
每股收益（稀释后）LIVNRAMP
| Q4 25 | $0.57 | $0.62 | ||
| Q3 25 | $0.49 | $0.42 | ||
| Q2 25 | $0.50 | $0.12 | ||
| Q1 25 | $-6.01 | $-0.10 | ||
| Q4 24 | $1.04 | $0.17 | ||
| Q3 24 | $0.60 | $0.03 | ||
| Q2 24 | $0.30 | $-0.11 | ||
| Q1 24 | $-0.78 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.6M | $403.4M |
| 总债务越低越好 | $376.1M | — |
| 股东权益账面价值 | $1.2B | $962.3M |
| 总资产 | $2.6B | $1.3B |
| 负债/权益比越低杠杆越低 | 0.31× | — |
8季度趋势，按日历期对齐
现金及短期投资LIVNRAMP
| Q4 25 | $635.6M | $403.4M | ||
| Q3 25 | $646.1M | $376.9M | ||
| Q2 25 | $593.6M | $371.1M | ||
| Q1 25 | $738.4M | $420.8M | ||
| Q4 24 | $428.9M | $384.3M | ||
| Q3 24 | $346.4M | $348.4M | ||
| Q2 24 | $329.2M | $342.7M | ||
| Q1 24 | $309.2M | $368.9M |
总债务LIVNRAMP
| Q4 25 | $376.1M | — | ||
| Q3 25 | $434.5M | — | ||
| Q2 25 | $430.6M | — | ||
| Q1 25 | $628.2M | — | ||
| Q4 24 | $627.0M | — | ||
| Q3 24 | $625.5M | — | ||
| Q2 24 | $624.5M | — | ||
| Q1 24 | $623.8M | — |
股东权益LIVNRAMP
| Q4 25 | $1.2B | $962.3M | ||
| Q3 25 | $1.2B | $943.8M | ||
| Q2 25 | $1.1B | $947.8M | ||
| Q1 25 | $1.0B | $948.9M | ||
| Q4 24 | $1.3B | $957.7M | ||
| Q3 24 | $1.3B | $932.1M | ||
| Q2 24 | $1.2B | $951.9M | ||
| Q1 24 | $1.2B | $949.1M |
总资产LIVNRAMP
| Q4 25 | $2.6B | $1.3B | ||
| Q3 25 | $2.6B | $1.2B | ||
| Q2 25 | $2.5B | $1.2B | ||
| Q1 25 | $2.6B | $1.3B | ||
| Q4 24 | $2.5B | $1.3B | ||
| Q3 24 | $2.5B | $1.2B | ||
| Q2 24 | $2.5B | $1.2B | ||
| Q1 24 | $2.5B | $1.2B |
负债/权益比LIVNRAMP
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.4M | — |
| 自由现金流经营现金流 - 资本支出 | $50.2M | — |
| 自由现金流率自由现金流/营收 | 13.9% | — |
| 资本支出强度资本支出/营收 | 8.9% | 0.1% |
| 现金转化率经营现金流/净利润 | 2.67× | — |
| 过去12个月自由现金流最近4个季度 | $173.3M | — |
8季度趋势，按日历期对齐
经营现金流LIVNRAMP
| Q4 25 | $82.4M | — | ||
| Q3 25 | $85.1M | $57.4M | ||
| Q2 25 | $62.9M | $-15.8M | ||
| Q1 25 | $24.0M | — | ||
| Q4 24 | $78.7M | $45.1M | ||
| Q3 24 | $51.0M | $55.6M | ||
| Q2 24 | $43.4M | $-9.3M | ||
| Q1 24 | $10.0M | — |
自由现金流LIVNRAMP
| Q4 25 | $50.2M | — | ||
| Q3 25 | $62.2M | $56.8M | ||
| Q2 25 | $47.8M | $-16.2M | ||
| Q1 25 | $13.2M | — | ||
| Q4 24 | $68.3M | $44.8M | ||
| Q3 24 | $32.8M | $55.4M | ||
| Q2 24 | $31.2M | $-9.6M | ||
| Q1 24 | $3.6M | — |
自由现金流率LIVNRAMP
| Q4 25 | 13.9% | — | ||
| Q3 25 | 17.4% | 28.4% | ||
| Q2 25 | 13.6% | -8.3% | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 21.2% | 22.9% | ||
| Q3 24 | 10.3% | 29.8% | ||
| Q2 24 | 9.8% | -5.4% | ||
| Q1 24 | 1.2% | — |
资本支出强度LIVNRAMP
| Q4 25 | 8.9% | 0.1% | ||
| Q3 25 | 6.4% | 0.3% | ||
| Q2 25 | 4.3% | 0.2% | ||
| Q1 25 | 3.4% | 0.2% | ||
| Q4 24 | 3.2% | 0.1% | ||
| Q3 24 | 5.7% | 0.1% | ||
| Q2 24 | 3.8% | 0.1% | ||
| Q1 24 | 2.2% | 1.0% |
现金转化率LIVNRAMP
| Q4 25 | 2.67× | — | ||
| Q3 25 | 3.18× | 2.09× | ||
| Q2 25 | 2.32× | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.41× | 4.02× | ||
| Q3 24 | 1.55× | 32.10× | ||
| Q2 24 | 2.65× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIVN
| Other | $169.4M | 47% |
| Neuromodulation Segment | $119.7M | 33% |
| Cardiopulmonary Segment | $71.8M | 20% |
RAMP
暂无分部数据
